arrow
C

Clara Hartmanshenn

merck & co., inc.
H指数:9
被引数:987

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biocatalytic cascades enable manufacture of the macrocyclic peptide enlicitide

生物催化级联实现大环肽enlicitide的制造

Science
IF45.8
2026-05-070
PRE
Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19

MK-7845的不对称合成,新型冠状病毒肺炎的研究性治疗

2025-10-010
PRE
Total Synthesis of Enlicitide Decanoate

恩利西肽癸酸酯的全合成

2025-03-243
PRE
Rapid End-Game Process Development and First GMP Production of MK-7845: An Experimental Antiviral Treatment for COVID-19
2024-06-062
PRE
Development of a Green and Sustainable Manufacturing Process for a Key Intermediate to Nemtabrutinib (MK-1026): Sequential Deprotonation-Lithiation as a Batch-Flow Process
2024-05-090
PRE
Leveraging Synergistic Solubility in the Development of a Direct Isolation Process for Nemtabrutinib

在开发Nemtabrutinib的直接隔离过程中利用协同溶解度

2023-03-107
PRE